NCT07877727
Empowering the Clinical Management of BMFs Through a Biological and Genetically Driven Pediatric and Adult National Network
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
- Minor Study completion pushed from Dec 31, 2026 to Feb 28, 2027
- Site details revised at 1 of 4 sites
- Study title shortened, about 2 words
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
Early Diagnosis and Molecular Characterization of CMF and AAA
Timeframe: Within the 24-month project period
Arms and interventions
Fanconi anemia (FA)
Fanconi anemia (FA)
Dyskeratosis congenita (DC) e altri telomere biology disorders (TBD)
Dyskeratosis congenita (DC) e altri telomere biology disorders (TBD)
Congenital neutropenia (CN)
Congenital neutropenia (CN)
Primary immune regulatory disorders (PIRD)
Primary immune regulatory disorders (PIRD)
Congenital amegakaryocytic thrombocytopenia (CAMT)
Congenital amegakaryocytic thrombocytopenia (CAMT)
Acquired aplastic anemia (AAA), with or without paroxysmal nocturnal hemoglobinuria (PNH)
Acquired aplastic anemia (AAA), with or without paroxysmal nocturnal hemoglobinuria (PNH)
Sites
4 sites in 1 country